|

KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

RECRUITINGSponsored by Seoul National University Hospital
Actively Recruiting
SponsorSeoul National University Hospital
Started2019-05-01
Est. completion2028-12-31
Eligibility
Healthy vol.Accepted

Summary

Glomerulonephritis (GN) generates an enormous individual and social economic burden. However, the therapeutic options are largely based on clinical and pathological parameters and the individual response to therapy or prognosis is uncertain. Recently, along with advances in molecular analysis and computational bioinformatics, genomic data from human renal biopsies could provide a strong foundation for the future of precision medicine in nephrology. In response to a request for applications by the Ministry of Health and Welfare of Korea for the creation of Clinical Research Registry, multi-center N network has been established for prospective cohort with kidney biopsy samples (KORNERSTONE). Through this Network the investigators hope to understand the fundamental biology of glomerulonephritis and aim to bank long-term observational data and corresponding biological data including genomic data from kidney tissues, and kidney pathologic data which is digitalized This database is archived to a web-based platform to access easily and further enrich for researchers.

Eligibility

Healthy volunteers accepted
1. Inclusion criteria

   * Patient suspected of glomerular disease who received kidney biopsy in participating university medical centers
   * Children (age\<18 years) also included
2. Exclusion criteria - Patients who previously received a kidney transplant

Conditions8

Crescentic GlomerulonephritisFocal Segmental GlomerulosclerosisGlomerular DiseaseIgA NephropathyLupusLupus NephritisMembranous NephropathyMinimal Change Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.